2014, Number 4
<< Back Next >>
An Med Asoc Med Hosp ABC 2014; 59 (4)
The effect of the surgical patch Tachosil as hemostatic and lymph vessel sealing agent in breast cancer patients with axilar lymphadenectomy
Sharmiashvili NI,Pérez VM, Ghaddar RL
Language: Spanish
References: 14
Page: 257-260
PDF size: 213.03 Kb.
ABSTRACT
Introduction: Breast cancer is the most common malignancy in women and its treatment is multidisciplinary: local and systemic. The most important aspect of the cancer management is locoregional surgery. The morbidity of lymphadenectomy affects about 80% of patients with dissections level I and II of Berg.
Objective: We studied the impact of the surgical patch Tachosil in reducing the volume and permanence of postoperative axillary drainage, hospital stay, and seroma formation.
Material and methods: We analyzed 20 patients undergoing lymphadenectomy at the Hospital de La Princesa from February 2008 to February 2009. In these patients, we used Tachosil patch as a hemostatic and an agent for sealing capillaries and lymph.
Results: The overall average hospital stay: 7.75 days, axillary drainage debit: 300.35 cm
3 on average, and the axillary drainage duration was the same as the time of hospital stay. Complications: seroma, 5 (25%); surgical wound infection, 2 (10%); allergic reaction, 1 (5%).
Conclusion: There are very few reports in the literature on the use of Tachosil in breast cancer. In our study, we did not observe an important decrease in the axillary drainage; therefore ,we recommend conducting a prospective study with a larger and more homogeneous sample.
REFERENCES
Lacoste C, Ouldamer L, Body G, Marret H. L’utilisation du TachoSil permet-elle de reduire la morbidite du curage axillaire? Gynécologie, Obstetrique & Fertilité. 2013; 41 (2): 141-143.
Román JM, Moreno A, Vidart JA. Fundamentos de la biopsia del ganglio centinela en el cáncer de mama. Psicooncologia. 2005; 1 (2): 131-138.
Berger A, Tempfer C, Hartmann B, Kornprat P, Rossmann A, Neuwirth G et al. Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. Breast Cancer Res Treat. 2001; 67 (1): 9-14.
Haagensen CD. Treatment of curable carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1977; 2: 975-980.
Anegg U, Lindenmann J, Matzi V, Smolle J, Maier A, Smolle-Jüttner F. Efficiency of fleece-bound sealing (TachoSil) of air leaks in lung surgery: a prospective randomised trial. Eur J Cardiothorac Surg. 2007; 31 (2): 198-202.
Kallinowski F, Pfeil T, Ulbrich W. Quality management in surgical intervention –A prospective outcomes research study of fleece-bound tissue gluing (TachoSil). Gesundh Ökon Qual Manag. 2005; 10: 151-159.
Dawson I, Stam L, Heslinga JM, Kalsbeek HL. Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy: a randomized prospective clinical trial. Br J Surg. 1989; 76: 311-312.
Sitzmann JV, Dufresne C, Zuidema GD. The use of sclerotherapy for treatment of postmastectomy wound seromas. Surgery. 1983; 93: 345-347.
Coons MS, Folliguet TA, Rodriguez C, Woloszyn TT, Tuchler RE, Marini CP. Prevention of seroma formation after dissection of musculocutaneous flaps. Am Surg 1993; 59: 215-218.
Morris AM. A controlled trial of closed wound suction. Br J Surg. 1973; 60: 357-359.
Coveney EC, O’Dwyer PJ, Geraghty JG, O’Higgins NJ. Effect of closing dead space on seroma formation after mastectomy: a prospective randomized clinical trial. Eur J Surg Oncol. 1993; 19: 143-146.
Harada RN, Pressler VM, McNamara JJ. Fibrin-glue reduces seroma formation in the rat after mastectomy. Surg Gynecol Obstet. 1992; 175: 450-454.
Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg. 1997; 63: 97-102.
Burak WE Jr, Goodman PS, Young DC, Farrar WB. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol 1997; 64: 27-31.